enfrdeitptrues

Current Trials

Liberty 2 Uterine Fibroid Study

About the Liberty 2 Study

Soapstone Center for Clinical Research is looking for women to participate in a research study to evaluate whether an investigational medicine could reduce the amount of heavy menstrual bleeding due to uterine fibroids.
 





TO QUALIFY you must...

    • Are 18 to 50 years of age
    •  Have monthly menstrual periods
    •  Experience heavy menstrual bleeding due to uterine fibroids
    •  Have days when their feminine products (pads, tampons, liners) become soaked and need to be changed more than 3 times a day
    •  Additional requirements apply


      STUDY PARTICIPANTS

      • Receive study medication at no cost
      • Receive study-related medical exams
      • Are not required to have insurance
      • May be reimbursed for time, travel and other expenses





      Soapstone Center for Clinical Research is looking for women to participate in a research study to evaluate whether an investigational medicine could reduce the amount of heavy menstrual bleeding due to uterine fibroids.

      The first step to find out if you are eligible for the LIBERTY 2 research study is to go through a screening process, so a physician and other research health care professionals can ensure you meet criteria for the study.

      Some examples of criteria that must be met to participate in the LIBERTY 2 research study will be women who:

      • Are 18 to 50 years of age
      • Have monthly menstrual periods
      • Experience heavy menstrual bleeding associated with uterine fibroids
      • Have days when their feminine products (pads, tampons, liners) become soaked and need to be changed more than 3 times a day
      • Additional requirements apply

      Qualified participants will receive:

      •   Medical exams
      •  Compensation for time and travel

      We want you to help advance women's health research! If you are interested in participating, please call the
      Soapstone Center for Clinical Research at 404-534-9359

      Principal Investigator: Peter Johnson, MD

      Sponsor:  Myovant Sciences GmbH

      Research Coordinator(s): Natalie 404-534-9359 

       

      Trial Interest Form
      1000 characters left